146 related articles for article (PubMed ID: 1034180)
1. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
Jonsson G
Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
[TBL] [Abstract][Full Text] [Related]
2. Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol.
Cohen G; Heikkila RE; Allis B; Cabbat F; Dembiec D; MacNamee D; Mytilineou C; Winston B
J Pharmacol Exp Ther; 1976 Nov; 199(2):336-52. PubMed ID: 185360
[TBL] [Abstract][Full Text] [Related]
3. Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium.
Luthman J; Jonsson G
Med Biol; 1986; 64(2-3):95-102. PubMed ID: 3489145
[TBL] [Abstract][Full Text] [Related]
4. Noradrenaline and dopamine interaction in rat brain during development.
Ponzio F; Hallman H; Jonsson G
Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
[TBL] [Abstract][Full Text] [Related]
5. Resistance of central phenylethanolamine-n-methyl transferase containing neurons to 6-hydroxydopamine.
Jonsson G; Fuxe K; Hökfelt T; Goldstein M
Med Biol; 1976 Dec; 54(6):421-6. PubMed ID: 1004027
[TBL] [Abstract][Full Text] [Related]
6. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.
Sachs C; Jonsson G
Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547
[TBL] [Abstract][Full Text] [Related]
7. Control of the neurotoxicity of 6-hydroxydopamine by intraneuronal noradrenaline in rat iris.
Sachs C; Jonsson G; Heikkila R; Cohen G
Acta Physiol Scand; 1975 Mar; 93(3):345-51. PubMed ID: 1096534
[TBL] [Abstract][Full Text] [Related]
8. Isomers of 2,4,5-trihydroxyphenethylamine (6-hydroxydopamine): long-term effects on the accumulation of (3H)-norepinephrine in mouse heart in vivo.
Lundstrom J; Ong H; Daly J; Creveling CR
Mol Pharmacol; 1973 Jul; 9(4):505-13. PubMed ID: 4725781
[No Abstract] [Full Text] [Related]
9. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
Javitch JA; Blaustein RO; Snyder SH
Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
[TBL] [Abstract][Full Text] [Related]
10. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
Carli M; Afkhami-Dastjerdian S; Reader TA
J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
[TBL] [Abstract][Full Text] [Related]
11. Noradrenergic innervation of serotoninergic neurons in the myenteric plexus.
Gershon MD; Sherman DL
J Comp Neurol; 1987 May; 259(2):193-210. PubMed ID: 3584557
[TBL] [Abstract][Full Text] [Related]
12. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
[TBL] [Abstract][Full Text] [Related]
13. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
Jonsson G; Malmfors T; Sachs C
Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
[No Abstract] [Full Text] [Related]
14. 6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves.
de Champlain J; Nadeau R
Fed Proc; 1971; 30(3):877-85. PubMed ID: 4324975
[No Abstract] [Full Text] [Related]
15. Protection by desipramine of 6-hydroxydopamine induced damage to adrenergic nerve terminals in mouse heart.
Bonagura V; Cassebaum L; Dangman K; Freund J; Cabbat F; Dembiec D; Heikkila R; Cohen G
Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):163-71. PubMed ID: 4671960
[No Abstract] [Full Text] [Related]
16. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration.
Crews FT; Smith CB
J Pharmacol Exp Ther; 1980 Oct; 215(1):143-9. PubMed ID: 6256516
[TBL] [Abstract][Full Text] [Related]
17. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
Jonsson G; Sachs C
Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
[No Abstract] [Full Text] [Related]
18. Prevention of 6-hydroxydopamine neurotoxicity.
Cohen G; Allis B; Winston B; Mytilineou C; Heikkila R
Eur J Pharmacol; 1975 Aug; 33(1):217-21. PubMed ID: 1175689
[TBL] [Abstract][Full Text] [Related]
19. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
O'Donnell JM; Seiden LS
J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
[TBL] [Abstract][Full Text] [Related]
20. [Functional role of noradrenergic neurons in the hypothermic effect of apomorphine and other dopaminomimetics].
Shchelkunov EL; Andreeva OG; Korovin KF; Ostroumova MN
Farmakol Toksikol; 1980; 43(5):558-63. PubMed ID: 7449984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
